Susquehanna International Group’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$457K Sell
46,015
-122,973
-73% -$1.22M ﹤0.01% 4448
2025
Q1
$1.6M Sell
168,988
-112,314
-40% -$1.07M ﹤0.01% 2599
2024
Q4
$3.88M Buy
281,302
+157,890
+128% +$2.18M ﹤0.01% 1274
2024
Q3
$1.88M Buy
123,412
+82,915
+205% +$1.26M ﹤0.01% 1909
2024
Q2
$193K Sell
40,497
-275,763
-87% -$1.32M ﹤0.01% 4765
2024
Q1
$2.15M Buy
316,260
+167,145
+112% +$1.13M ﹤0.01% 1733
2023
Q4
$729K Buy
149,115
+19,840
+15% +$97K ﹤0.01% 3319
2023
Q3
$442K Buy
129,275
+80,640
+166% +$276K ﹤0.01% 3585
2023
Q2
$232K Buy
48,635
+14,117
+41% +$67.5K ﹤0.01% 4502
2023
Q1
$146K Sell
34,518
-94,552
-73% -$399K ﹤0.01% 5057
2022
Q4
$498K Sell
129,070
-16,361
-11% -$63.2K ﹤0.01% 3232
2022
Q3
$873K Sell
145,431
-24,206
-14% -$145K ﹤0.01% 2726
2022
Q2
$592K Buy
169,637
+11,175
+7% +$39K ﹤0.01% 3127
2022
Q1
$544K Sell
158,462
-56,139
-26% -$193K ﹤0.01% 3602
2021
Q4
$629K Sell
214,601
-23,764
-10% -$69.7K ﹤0.01% 3472
2021
Q3
$958K Sell
238,365
-42,580
-15% -$171K ﹤0.01% 2814
2021
Q2
$1.44M Buy
280,945
+72,719
+35% +$373K ﹤0.01% 2481
2021
Q1
$974K Buy
208,226
+26,473
+15% +$124K ﹤0.01% 3037
2020
Q4
$623K Sell
181,753
-102,483
-36% -$351K ﹤0.01% 3159
2020
Q3
$1.49M Buy
284,236
+165,414
+139% +$868K ﹤0.01% 1725
2020
Q2
$547K Buy
+118,822
New +$547K ﹤0.01% 2833
2017
Q1
Sell
-1,432
Closed -$38K 3356
2016
Q4
$38K Buy
+1,432
New +$38K ﹤0.01% 4009
2016
Q1
Sell
-1,570
Closed -$48K 3884
2015
Q4
$48K Buy
+1,570
New +$48K ﹤0.01% 4054